Trypanosoma cruzi Adjuvants Potentiate T Cell-Mediated Immunity Induced by a NY-ESO-1 Based Antitumor Vaccine

Immunological adjuvants that induce T cell-mediate immunity (TCMI) with the least side effects are needed for the development of human vaccines. Glycoinositolphospholipids (GIPL) and CpGs oligodeoxynucleotides (CpG ODNs) derived from the protozoa parasite Trypanosoma cruzi induce potent pro-inflamma...

Descripción completa

Detalles Bibliográficos
Autores principales: Junqueira, Caroline, Guerrero, Ana Tereza, Galvão-Filho, Bruno, Andrade, Warrison A., Salgado, Ana Paula C., Cunha, Thiago M., Ropert, Catherine, Campos, Marco Antônio, Penido, Marcus L. O., Mendonça-Previato, Lúcia, Previato, José Oswaldo, Ritter, Gerd, Cunha, Fernando Q., Gazzinelli, Ricardo T.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2012
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3342165/
https://www.ncbi.nlm.nih.gov/pubmed/22567144
http://dx.doi.org/10.1371/journal.pone.0036245

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3342165/
https://www.ncbi.nlm.nih.gov/pubmed/22567144
http://dx.doi.org/10.1371/journal.pone.0036245

Ejemplares similares